Assignee
ORE PHARMACEUTICALS INC
US·4 granted patents·9 pending applications·18 citations·filing 2003–2009
Top patents by PatentIndex Score
13 records- 0183US7790719B2Modulators of melanocortin receptorORE PHARMACEUTICALS INC·Filed 2007·Granted Sep 7, 2010·7 cites·18 claims
- 0280US7842709B2Method for treating inflammatory diseases of the digestive tractORE PHARMACEUTICALS INC·Filed 2007·Granted Nov 30, 2010·8 cites·19 claims
- 0364US7365070B2Modulators of melanocortin receptorORE PHARMACEUTICALS INC·Filed 2003·Granted Apr 29, 2008·2 cites·21 claims
- 0461US7375125B2Melanocortin-4 receptor binding compounds and methods of use thereofORE PHARMACEUTICALS INC·Filed 2003·Granted May 20, 2008·1 cites·30 claims
- 0558US2009325238A1Method of Analyzing a BRCA2 Gene in a Human SubjectORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0658US2009325237A1Method of Analyzing a BRCA2 Gene in a Human SubjectORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 0756US2009012052A1Method for treating er+ breast cancerORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0855US2008269217A1Melanocortin-4 receptor binding compounds and methods of use thereofORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 0954US2009192220A1Treatment for solid tumorsORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1054US2009186014A1Method for treatment of pancreatitisORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1152US2010209914A1Methods, systems, and kits for evaluating multiple sclerosisORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1248US2010029734A1Methods for breast cancer screening and treatmentORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1343US2010069400A1Methods for treating inflammation and related conditionsORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ORE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →